Page last updated: 2024-09-05

ml 23 and triiodothyronine

ml 23 has been researched along with triiodothyronine in 1 studies

Compound Research Comparison

Studies
(ml 23)
Trials
(ml 23)
Recent Studies (post-2010)
(ml 23)
Studies
(triiodothyronine)
Trials
(triiodothyronine)
Recent Studies (post-2010) (triiodothyronine)
131026,2478613,473

Protein Interaction Comparison

ProteinTaxonomyml 23 (IC50)triiodothyronine (IC50)
Thyroid hormone receptor alphaHomo sapiens (human)0.0006
Thyroid hormone receptor betaHomo sapiens (human)0.0006
Proliferating cell nuclear antigenHomo sapiens (human)3.6
Thyroid hormone receptor betaRattus norvegicus (Norway rat)0.0031
Adenosine receptor A1Homo sapiens (human)0.4109

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Migliaccio, S; Nordio, M; Reiter, RJ; van Jaarsveld, A; Vaughan, MK; Zisapel, N1

Other Studies

1 other study(ies) available for ml 23 and triiodothyronine

ArticleYear
A novel melatonin antagonist, N-(2,4-dinitrophenyl)-5-methoxytryptamine neutralizes some effects of melatonin in the female Syrian hamster.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1989, Volume: 191, Issue:4

    Topics: 5-Methoxytryptamine; Animals; Cricetinae; Estradiol; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Melatonin; Mesocricetus; Organ Size; Ovary; Pituitary Gland; Progesterone; Prolactin; Serotonin; Thyroxine; Triiodothyronine; Uterus

1989